Ioannis Tentzeris
Ottakring, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Blood group non-O is not associated with long-term adverse outcomes in patients undergoing percutaneous coronary intervention.
Journal: Thrombosis research
Published: January 11, 2023
Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
Journal: Frontiers in cardiovascular medicine
Published: September 24, 2021
Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: December 14, 2020
Effect of marathon and ultra-marathon on inflammation and iron homeostasis.
Journal: Scandinavian journal of medicine & science in sports
Published: July 30, 2020
Impact of ultra-marathon and marathon on biomarkers of myocyte necrosis and cardiac congestion: a prospective observational study.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: December 02, 2019
Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome.
Journal: European journal of preventive cardiology
Published: June 04, 2019
Prognostic Impact of Soluble P-Selectin on Long-Term Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
Journal: Thrombosis and haemostasis
Published: December 29, 2018
A Sex-Specific Analysis of the Predictive Value of Troponin I and T in Patients With and Without Diabetes Mellitus After Successful Coronary Intervention.
Journal: Frontiers in endocrinology
Published: September 24, 2018
High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure.
Journal: International journal of cardiology
Published: April 30, 2018
Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy.
Journal: The American journal of cardiology
Published: January 06, 2017
Last Updated: 09/26/2026